MGF IGF-1 EC (5mg)

€145.00

Size: 5mg
Contents: MGF IGF-1 EC
Form: Lyophilized powder
Purity: >99%
SKU: P-MGF-IGF-1-EC

Categories: Peptides for Sale, Research Peptides for Sale

Description
Reviews (0)

MGF IGF-1 EC (5mg) – Mechano Growth Factor Research Peptide

MGF IGF-1 EC (5mg), also known as Mechano Growth Factor (MGF), MGF E or MGF-Ct24E, is a synthetic peptide fragment associated with the human insulin-like growth factor 1 (IGF-1) system. It corresponds to the C-terminal 24 amino acids of the Ec peptide associated with the IGF-1Ec splice variant.

MGF IGF-1 EC has been investigated in laboratory research involving muscle-cell biology, differentiation, migration, tissue signalling and IGF-1-related pathways. The referenced product is listed as 5mg of lyophilised powder with a stated purity of >99%. It is presented as a research material rather than an approved medicine or therapeutic product.

MGF IGF-1 EC is particularly interesting because it represents only a specific portion of the larger IGF-1Ec precursor. Scientific research has demonstrated that the C-terminal MGF E peptide can exhibit biological characteristics that differ from mature IGF-1, making it a useful experimental compound for investigating non-classical IGF-related signalling.

What Is MGF IGF-1 EC?

MGF IGF-1 EC refers to a peptide fragment derived from the C-terminal region of the human IGF-1Ec splice product. IGF1 undergoes alternative splicing, producing several related precursor molecules with different E-peptide sequences. In humans, IGF-1Ec is commonly associated with the term Mechano Growth Factor or MGF.

The synthetic MGF E peptide commonly investigated in research corresponds to the last 24 amino acids of the Ec peptide. This shorter fragment is frequently identified in scientific literature as MGF E, MGF-Ct24E or simply MGF.

It is important to distinguish the synthetic 24-amino-acid MGF peptide from the complete endogenous IGF-1Ec precursor. These are related but structurally different research materials and should not automatically be assumed to have identical biological functions.

MGF IGF-1 EC (5mg) Product Overview

Specification	Details
Product Name	MGF IGF-1 EC
Alternative Names	Mechano Growth Factor, MGF E, MGF-Ct24E
Quantity	5mg
Form	Lyophilised powder
Stated Purity	>99%
Molecular Weight	2971.99 g/mol
Molecular Formula	C₁₂₄H₂₀₄N₄₂O₄₁S
Peptide Classification	IGF-1-derived research peptide
Primary Research Areas	Muscle-cell biology, IGF-1 signalling, differentiation and tissue research
Intended Application	Research and laboratory use only

The product specifications above reflect the referenced Core Peptides listing. Researchers should consult the relevant batch documentation and certificate of analysis for definitive analytical specifications.

MGF IGF-1 EC and IGF-1 Alternative Splicing

The biological background of MGF IGF-1 EC begins with the IGF1 gene. Through alternative splicing, IGF1 can generate several precursor transcripts with different C-terminal E-peptide sequences.

Human IGF-1Ec contains a distinctive Ec domain resulting from alternative splicing. Research has identified this isoform as being particularly relevant to skeletal-muscle responses to mechanical stress and exercise-related tissue changes.

After translation, IGF-1 precursor proteins undergo processing. Research has provided evidence that the human Ec peptide can be generated from the pro-IGF-1Ec precursor and can exist as a free peptide in tissues.

This processing pathway is one reason MGF IGF-1 EC has become an area of interest in peptide and cellular biology research.

MGF IGF-1 EC Structure

MGF IGF-1 EC is commonly described in research as a 24-amino-acid C-terminal peptide derived from the Ec region of IGF-1.

This relatively short sequence is structurally distinct from mature IGF-1, which is a larger peptide hormone. Consequently, experimental findings involving MGF E should not automatically be interpreted as equivalent to findings involving mature IGF-1.

Research comparing IGF-1Ec, mature IGF-1 and the MGF E peptide has demonstrated that different portions of the IGF-1Ec molecule can produce different cellular responses.

MGF IGF-1 EC vs Mature IGF-1

Characteristic	MGF IGF-1 EC	Mature IGF-1
Origin	C-terminal Ec region associated with IGF-1Ec	Mature IGF-1 portion common to IGF-1 precursor isoforms
Common Research Name	MGF E / MGF-Ct24E	IGF-1
Structure	Short C-terminal peptide fragment	Larger mature peptide hormone
Research Interest	Cell migration, differentiation and non-classical signalling	Growth, metabolism and IGF-1 receptor signalling
Receptor Behaviour	Does not necessarily reproduce classical IGF-1R signalling	Established interaction with IGF-1 receptor

Experimental evidence indicates that MGF E and mature IGF-1 can produce different effects in muscle-cell models. One study found that the C-terminal MGF E sequence promoted differentiation and migration, whereas other regions of IGF-1Ec were associated with proliferation.

MGF IGF-1 EC and Muscle-Cell Research

One of the principal research areas for MGF IGF-1 EC is skeletal-muscle cell biology.

Early research identified MGF as an IGF-1 splice variant associated with mechanical stress and muscle adaptation. Following muscle injury or mechanical loading, changes in IGF-1 splice-variant expression have been observed, providing a basis for studying MGF in tissue-remodelling research.

Experimental studies have subsequently examined synthetic MGF E peptides in cultured muscle cells and myogenic progenitor cells. Reported research endpoints have included:

Cell proliferation.
Cell migration.
Myogenic differentiation.
Myoblast fusion.
Myotube formation.
Cellular signalling.
Changes in muscle-specific gene expression.

Results vary depending on the experimental model and the exact MGF construct used, so laboratory findings should be interpreted within the context of the individual study.

MGF IGF-1 EC and Muscle Progenitor Cells

Muscle progenitor cells are important for skeletal-muscle maintenance and regeneration. MGF E has been investigated as a potential signalling molecule involved in the behaviour of these cells.

A study of human muscle progenitor cells reported that MGF E influenced their activity and increased their fusion potential in experimental models. The authors also investigated age-related differences in muscle progenitor-cell responses.

Other work has examined how the MGF E sequence affects myoblast differentiation and migration. Research using C2C12 cells reported that the MGF E region of IGF-1Ec had distinct effects compared with mature IGF-1.

MGF IGF-1 EC and Cellular Differentiation

Cellular differentiation is another important area of MGF research.

In a C2C12 muscle-cell model, researchers found that different portions of IGF-1Ec could produce different responses. The C-terminal sequence corresponding to MGF E promoted differentiation and migration, while the N-terminal portion shared with IGF-1 was associated with proliferation.

These findings support the concept that the individual domains of IGF-1 splice variants may have distinct biological functions.

For research purposes, this makes MGF IGF-1 EC useful for studying how specific peptide sequences can influence cellular phenotype and signalling independently from the complete IGF-1 molecule.

MGF IGF-1 EC and Cell Signalling

MGF IGF-1 EC has received attention because its signalling characteristics may differ from conventional IGF-1 signalling.

The referenced product literature notes research indicating that the MGF E peptide does not measurably induce classical IGF-1 receptor tyrosine phosphorylation or activate the insulin receptor in certain experimental systems. Instead, studies have associated the peptide with ERK-related signalling pathways.

These findings are particularly interesting because mature IGF-1 is strongly associated with canonical IGF-1 receptor signalling. Comparing MGF E with mature IGF-1 therefore provides a useful experimental model for examining alternative signalling mechanisms.

MGF IGF-1 EC and ERK Signalling

ERK signalling is a major intracellular pathway involved in cellular growth, differentiation and adaptation.

Research into MGF E has investigated activation of ERK-family pathways as a possible mechanism underlying some of its observed cellular effects. Experimental studies have reported ERK-related activity in cells exposed to MGF E, although the exact receptor and signalling mechanisms remain an area of investigation.

Because signalling outcomes can depend on cell type and experimental conditions, ERK-related findings should be considered experimental rather than evidence of a defined therapeutic mechanism in humans.

MGF IGF-1 EC and Muscle Hypertrophy Research

MGF IGF-1 EC has frequently been discussed in relation to experimental studies of muscle hypertrophy.

Some research has reported changes in cell volume, protein content and muscle-specific gene expression following exposure to synthetic MGF E in cultured cells. The Core Peptides product literature describes research examining ERK5- and MEF2C-associated pathways in smooth-muscle cells.

However, these findings should not be interpreted as proof that MGF IGF-1 EC increases muscle mass in humans. Laboratory observations involving cultured cells do not establish clinical efficacy, safety or appropriate human use.

MGF IGF-1 EC and Mechanical Stress

The name Mechano Growth Factor originates from research examining changes in IGF-1 expression following mechanical stimulation.

Studies of skeletal muscle have reported transient increases in MGF-related mRNA following exercise-induced muscle damage. This research has contributed to the hypothesis that IGF-1 splice variants may have specialised roles during the response to mechanical stress and tissue remodelling.

More recent investigations have also confirmed that human Ec peptide can be produced in tissues and may be regulated during muscle regeneration following exercise-induced damage.

MGF IGF-1 EC and Tissue Research

Although much of the research surrounding MGF focuses on skeletal muscle, the IGF-1Ec/MGF system has also been studied in several other tissues.

Experimental research has investigated MGF expression and activity in areas including:

Skeletal muscle.
Cardiac tissue.
Bone and cartilage.
Neural tissue.
Liver.
Reproductive tissues.
Cell-culture models of different tissue types.

Research has detected Ec/Eb peptide-related products in several tissues, including muscle, liver and heart, supporting further investigation into the biological roles of IGF-1 splice products beyond skeletal muscle.

MGF IGF-1 EC and Tissue Repair Research

MGF has historically been investigated in the context of tissue repair and regeneration. The original interest arose from observations connecting IGF-1 splice-variant expression with mechanical stress and muscle damage.

Experimental studies have explored whether MGF-related signalling contributes to cellular responses involved in tissue adaptation. These include changes in cell migration, differentiation and survival.

Such research remains predominantly experimental. It should not be interpreted as establishing MGF IGF-1 EC as a clinically validated treatment for muscle injuries, wounds or other tissue disorders.

MGF IGF-1 EC and Research on Muscle Regeneration

Muscle regeneration involves coordinated processes including satellite-cell activation, proliferation, migration, differentiation and fusion.

MGF-related IGF-1 splice variants have been investigated in several of these processes. Research following exercise-induced muscle damage has demonstrated distinct temporal patterns in MGF and other IGF-1 transcripts.

In-vitro research has also found that the MGF E region can influence muscle-cell migration and differentiation.

These observations make MGF IGF-1 EC a useful experimental material for researchers studying the molecular biology of muscle regeneration.

MGF IGF-1 EC and Receptor Research

One of the most interesting aspects of MGF IGF-1 EC research is its apparent difference from canonical IGF-1 receptor activity.

Studies have reported that synthetic MGF E peptide can produce biological responses without detectable activation of the classical IGF-1 receptor in particular experimental systems. Earlier work similarly suggested that MGF E could exert effects through a mechanism distinct from the conventional IGF-1 receptor.

However, receptor mechanisms remain incompletely characterised. Research has produced differing results depending on the peptide construct, assay system and cell type. Therefore, MGF IGF-1 EC should be regarded as an experimental signalling molecule rather than a peptide with a fully established receptor mechanism.

MGF IGF-1 EC vs Full-Length IGF-1Ec

Feature	MGF IGF-1 EC	Full-Length IGF-1Ec
Type	C-terminal Ec-derived peptide fragment	IGF-1Ec precursor/isoform
Length	24 amino acids for the commonly studied MGF E peptide	Longer precursor containing mature IGF-1 and Ec region
Relationship	Derived from the C-terminal region of Ec	Contains the Ec domain as part of the larger precursor
Research Focus	Peptide signalling, differentiation and migration	IGF-1 isoform biology and tissue-specific expression

Scientific literature specifically cautions that the synthetic MGF E peptide should not simply be treated as a complete substitute for full-length IGF-1Ec. Different regions of IGF-1Ec appear to contribute to different cellular responses.

MGF IGF-1 EC Research Applications

MGF IGF-1 EC may be relevant to qualified researchers studying:

IGF-1 alternative splicing: Investigating the generation of different IGF-1 isoforms.
Muscle-cell biology: Examining myoblast behaviour and muscle-cell signalling.
Cell differentiation: Studying changes in myogenic differentiation.
Cell migration: Investigating movement of muscle progenitor cells.
Muscle regeneration: Exploring molecular responses to mechanical stress and injury.
ERK signalling: Examining non-classical signalling pathways.
Peptide pharmacology: Comparing MGF E with mature IGF-1.
Structure-function research: Determining how specific IGF-1 domains affect cellular responses.
Tissue biology: Studying IGF-1Ec expression across different tissues.
Analytical research: Characterising peptide identity, purity and stability.

MGF IGF-1 EC and Experimental Models

Researchers have studied MGF IGF-1 EC using a variety of experimental systems, including cultured muscle cells, primary human muscle progenitor cells and tissue samples.

C2C12 cells have been particularly useful for investigating relationships between IGF-1Ec, mature IGF-1 and MGF E. Research in this model has demonstrated that different peptide regions can produce distinct effects on proliferation, differentiation and migration.

Human tissue studies have also examined MGF-related expression following exercise-induced muscle damage, providing additional information about the temporal regulation of IGF-1 splice variants.

MGF IGF-1 EC and Scientific Limitations

Despite substantial interest, MGF IGF-1 EC remains an area where important scientific questions are unresolved.

Terminology is one source of confusion. The terms MGF, IGF-1Ec, MGF E and MGF-Ct24E are sometimes used interchangeably even though they can refer to different molecular forms.

In addition, different studies have reported different signalling and cellular responses. Some research has suggested activity through ERK-related pathways, while other studies have questioned whether synthetic MGF E reproduces all of the functions attributed to endogenous IGF-1Ec.

For rigorous research, investigators should always identify the exact peptide sequence, molecular form, experimental model and analytical method used.

Why Study MGF IGF-1 EC?

MGF IGF-1 EC provides researchers with a focused way to investigate the biology of the IGF-1Ec E-domain without using the complete IGF-1 molecule.

Its scientific interest includes:

A defined C-terminal sequence derived from IGF-1Ec.
A substantial history of muscle-cell research.
Potentially distinct signalling compared with mature IGF-1.
Research relevance to cell migration and differentiation.
Applications in IGF-1 splice-variant studies.
Utility in structure-function experiments.
Relevance to mechanically stimulated tissue research.

Frequently Asked Questions About MGF IGF-1 EC (5mg)

What is MGF IGF-1 EC?

MGF IGF-1 EC is a synthetic peptide corresponding to the C-terminal 24 amino acids of the Ec peptide associated with the human IGF-1Ec splice variant. It is also commonly called MGF E or MGF-Ct24E.

What does MGF stand for?

MGF stands for Mechano Growth Factor. The term is associated with the IGF-1Ec splice variant and its related E-domain peptide.

Is MGF the same as IGF-1?

No. MGF IGF-1 EC is associated with a specific C-terminal region of an IGF-1 splice variant, whereas mature IGF-1 is a separate processed peptide with established IGF-1 receptor activity.

How long is the MGF IGF-1 EC peptide?

The synthetic MGF E peptide commonly discussed in research consists of the final 24 amino acids of the IGF-1Ec C-terminal region.

What is MGF-Ct24E?

MGF-Ct24E is another research name for the synthetic MGF E peptide corresponding to the C-terminal 24-amino-acid region of the IGF-1Ec E-domain.

What is MGF IGF-1 EC researched for?

Research applications include IGF-1 alternative splicing, muscle-cell biology, cellular differentiation, migration, tissue signalling, ERK pathways and peptide structure-function relationships.

Does MGF IGF-1 EC activate the IGF-1 receptor?

Research suggests that the synthetic MGF E peptide may produce cellular effects without detectable classical IGF-1 receptor activation in certain experimental systems. However, signalling mechanisms remain incompletely defined and results can vary by model.

Is MGF IGF-1 EC the same as full-length MGF?

No. The term MGF can refer to different molecular forms. The MGF IGF-1 EC product discussed here corresponds to the short C-terminal MGF E peptide, whereas full-length MGF-related proteins are substantially larger molecules.

Has MGF IGF-1 EC been studied in muscle cells?

Yes. Multiple experimental studies have investigated MGF E and IGF-1Ec in muscle-cell models, including research into proliferation, differentiation, migration and fusion potential.

Has MGF been detected naturally in human tissue?

Research has provided evidence that the human Ec peptide can be produced from the IGF-1Ec precursor in vivo and has been detected in tissues including muscle, liver and heart.

Is MGF IGF-1 EC an approved medicine?

No. Research-grade MGF IGF-1 EC should not be represented as an authorised medicine or as a clinically established treatment for muscle injury, tissue damage, ageing or any other medical condition.

What form is MGF IGF-1 EC (5mg) supplied in?

The referenced product is listed as 5mg of lyophilised powder with a stated purity greater than 99%. Researchers should review the relevant batch-specific analytical documentation for current specifications.

MGF IGF-1 EC (5mg) Research Summary

MGF IGF-1 EC (5mg) is a synthetic IGF-1-derived research peptide associated with the C-terminal 24-amino-acid region of the human IGF-1Ec E-domain. Also known as Mechano Growth Factor, MGF E and MGF-Ct24E, it has been investigated extensively in experimental research involving muscle-cell signalling, differentiation, migration and IGF-1 alternative splicing.

Research has demonstrated that the MGF E region can behave differently from mature IGF-1. Experimental studies have associated MGF E with changes in muscle-cell migration and differentiation, while other investigations have explored ERK-related signalling mechanisms that appear distinct from conventional IGF-1 receptor activation.

For qualified laboratories, MGF IGF-1 EC provides a useful experimental material for studying the relationship between IGF-1 alternative splicing, peptide structure, cellular signalling and muscle-cell biology.

Because the scientific literature contains differing findings and terminology, researchers should clearly distinguish the synthetic 24-amino-acid MGF E peptide from endogenous or full-length IGF-1Ec.

Research-Use Disclaimer

MGF IGF-1 EC (5mg) is intended for research, laboratory and analytical purposes only. It is not intended for human or animal consumption, self-administration, diagnosis, treatment, cure or prevention of any disease.

Research-grade MGF IGF-1 EC should not be marketed as an established muscle-building, recovery, anti-ageing or therapeutic medicine. Experimental findings involving cultured cells or animal models cannot be assumed to demonstrate safety or efficacy in humans.

Researchers should consult the current certificate of analysis and relevant safety documentation for the specific batch and conduct all work in accordance with applicable legislation, institutional requirements and appropriate laboratory safety procedures.

Reviews

There are no reviews yet.